Cargando…

Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets

The control of cardiovascular risk factors, the promotion of a healthy lifestyle, and antithrombotic therapy are the cornerstones of secondary prevention after acute coronary syndrome (ACS). However, many patients have recurrent ischemic events despite the optimal control of traditional modifiable r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silverio, Angelo, Cancro, Francesco Paolo, Esposito, Luca, Bellino, Michele, D’Elia, Debora, Verdoia, Monica, Vassallo, Maria Giovanna, Ciccarelli, Michele, Vecchione, Carmine, Galasso, Gennaro, De Luca, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056379/ https://www.ncbi.nlm.nih.gov/pubmed/36983163 http://dx.doi.org/10.3390/jcm12062161

Ejemplares similares

Soluble PCSK9 Inhibition: Indications, Clinical Impact, New Molecular Insights and Practical Approach—Where Do We Stand?
por: Bellino, Michele, et al.
Publicado: (2023)

Treatment and Outcome of Patients With Coronary Artery Ectasia: Current Evidence and Novel Opportunities for an Old Dilemma
por: Esposito, Luca, et al.
Publicado: (2022)

Acute Coronary Syndrome in Patients with SARS-CoV-2 Infection: Pathophysiology and Translational Perspectives
por: Cancro, Francesco P., et al.
Publicado: (2022)

Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients
por: Silverio, Angelo, et al.
Publicado: (2021)

Moving toward Precision Medicine in Acute Coronary Syndromes: A Multimodal Assessment of Non-Culprit Lesions
por: Bellino, Michele, et al.
Publicado: (2023)

COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives
por: Esposito, Luca, et al.
Publicado: (2021)

Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes
por: Silverio, Angelo, et al.
Publicado: (2022)

Timing of national lockdown and mortality in COVID-19: The Italian experience
por: Silverio, Angelo, et al.
Publicado: (2020)

Dynamic Left Intraventricular Obstruction Phenotype in Takotsubo Syndrome
por: Di Vece, Davide, et al.
Publicado: (2021)

Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?
por: Polito, Maria Vincenza, et al.
Publicado: (2021)

A Multistep Approach to Deal With Advanced Heart Failure: A Case Report on the Positive Effect of Cardiac Contractility Modulation Therapy on Pulmonary Pressure Measured by CardioMEMS
por: Visco, Valeria, et al.
Publicado: (2022)

Editorial: Advances in Percutaneous Coronary Intervention
por: Silverio, Angelo, et al.
Publicado: (2022)

The Role of Oxidative Stress in Cardiovascular Aging and Cardiovascular Diseases
por: Izzo, Carmine, et al.
Publicado: (2021)

Importance of Echocardiography and Clinical “Red Flags” in Guiding Genetic Screening for Fabry Disease
por: Citro, Rodolfo, et al.
Publicado: (2022)

Prognostic Implications of Right Ventricular Function and Pulmonary Pressures Assessed by Echocardiography in Hospitalized Patients with COVID-19
por: Polito, Maria Vincenza, et al.
Publicado: (2021)

Clinical outcome of patients with ST‐elevation myocardial infarction and angiographic evidence of coronary artery ectasia
por: Baldi, Cesare, et al.
Publicado: (2021)

Prognostic Impact of Mitral Regurgitation Before and After Transcatheter Aortic Valve Replacement in Patients With Severe Low‐Flow, Low‐Gradient Aortic Stenosis
por: Ferruzzi, Germano Junior, et al.
Publicado: (2023)

Clinical conditions and echocardiographic parameters associated with mortality in COVID‐19
por: Silverio, Angelo, et al.
Publicado: (2021)

A Novel Promising Frontier for Human Health: The Beneficial Effects of Nutraceuticals in Cardiovascular Diseases
por: Carrizzo, Albino, et al.
Publicado: (2020)

Exercise Training and Cardiac Rehabilitation in COVID-19 Patients with Cardiovascular Complications: State of Art
por: Calabrese, Mariaconsiglia, et al.
Publicado: (2021)

Bioprosthetic Valve Fracture After TAVR Complicated by Balloon Rupture: Bail-Out TAVR in TAVR in SAVR
por: Attisano, Tiziana, et al.
Publicado: (2022)

Role of multimodality imaging in evaluation of cardiovascular involvement in COVID-19
por: Citro, Rodolfo, et al.
Publicado: (2021)

A Novel Combination of High-Load Omega-3 Lysine Complex (AvailOm(®)) and Anthocyanins Exerts Beneficial Cardiovascular Effects
por: Di Pietro, Paola, et al.
Publicado: (2022)

Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction
por: Polito, Maria Vincenza, et al.
Publicado: (2020)

Balloon aortic valvuloplasty for urgent treatment of severe aortic stenosis during coronavirus disease 2019 pandemic: a case report
por: Attisano, Tiziana, et al.
Publicado: (2020)

Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems
por: Visco, Valeria, et al.
Publicado: (2022)

Big Health Data and Cardiovascular Diseases: A Challenge for Research, an Opportunity for Clinical Care
por: Silverio, Angelo, et al.
Publicado: (2019)

Platelets and the Atherosclerotic Process: An Overview of New Markers of Platelet Activation and Reactivity, and Their Implications in Primary and Secondary Prevention
por: Nardin, Matteo, et al.
Publicado: (2023)

Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease
por: Strianese, Oriana, et al.
Publicado: (2020)

Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEF
por: Visco, Valeria, et al.
Publicado: (2022)

Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve
por: Visco, Valeria, et al.
Publicado: (2023)

Vitamin D: Not Just Bone Metabolism but a Key Player in Cardiovascular Diseases
por: Izzo, Marcello, et al.
Publicado: (2021)

Optimal dual antiplatelet therapy strategy in elderly patients with acute coronary syndrome
por: Verdoia, Monica, et al.
Publicado: (2021)

Lipid Target in Very High-Risk Cardiovascular Patients: Lesson from PCSK9 Monoclonal Antibodies
por: Ciccarelli, Giovanni, et al.
Publicado: (2018)

The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers
por: Di Pietro, Paola, et al.
Publicado: (2023)

Abdominal Aortic Aneurysm: Natural History, Pathophysiology and Translational Perspectives
por: Accarino, Giulio, et al.
Publicado: (2022)

Transradial versus Transfemoral Approach in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome. A Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials
por: Piccolo, Raffaele, et al.
Publicado: (2014)

Impact of 719Trp>Arg Polymorphism of KIF 6 Gene on Contrast Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention
por: Barbieri, Lucia, et al.
Publicado: (2022)

Coronary Physiology: Modern Concepts for the Guidance of Percutaneous Coronary Interventions and Medical Therapy
por: Verdoia, Monica, et al.
Publicado: (2023)

Interventions to Address Cardiovascular Risk in Obese Patients: Many Hands Make Light Work
por: Visco, Valeria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0ff0m0bg2q1k78qk360e9e3uu2